News Daily News African-American ACS Patients Less Often Treated With Prasugrel After PCI Yael L. Maxwell January 24, 2019
News Daily News Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration Shelley Wood January 22, 2019
News Daily News Crushing It: Cangrelor and Ticagrelor Can Be Used Together Safely in STEMI, Small Study Hints Todd Neale January 14, 2019
News Daily News Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests Todd Neale January 09, 2019
News Daily News Tailoring Antiplatelet Therapy to Bleeding Risk Post-PCI Improves Outcomes and Cuts Costs, Model Suggests L.A. McKeown January 08, 2019
News Daily News Stroke Risk Increases Over Time in Many Patients With A-fib Todd Neale January 08, 2019
Partner Content SYNERGY-BP-DES-Optimizing Antiplatelet Therapy After PCI in Complex and High Bleeding Risk Patients - Boston Scientific November 15, 2019
Video » Topical Discussion SYNERGY BP-DES & Optimizing Antiplatelet Therapy after PCI in High-Bleeding Risk Patients October 8, 2019
Video » Interview ACC 2019: STOPDAPT-2 Trial: One-Month Dual Antiplatelet Therapy Followed by Clopidogrel Monotherapy versus Standard 12-Month Dual Antiplatelet Therapy with Clopidogrel After Drug-Eluting Stent Implantation March 18, 2019